Protected Percutaneous Coronary Intervention (PCI) of Cabrol Type Anastomosis of Saphenous Vein Graft (SVG) to the Left Main Coronary Artery (LMCA).

cabrol type anastomosis hemodynamics impella cp physiology pulsatility

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
25 Jun 2020
Historique:
entrez: 4 8 2020
pubmed: 4 8 2020
medline: 4 8 2020
Statut: epublish

Résumé

The use of percutaneous left ventricular assist devices (VAD) may minimize the risk of hemodynamic compromise during such high-risk percutaneous coronary intervention (PCI) and allow complete revascularization, thus improving outcomes. A good understanding of cardiac hemodynamics is essential in making informed decisions during such cases. A 61-year-old male with an extensive surgical cardiac history including a modified Cabrol type anastomosis with saphenous vein (SVG) conduits to two coronary arteries presented to our hospital with severe substernal chest discomfort and was noted to have diffuse ST depressions along with subtle ST elevations in lead aVR suggestive of diffuse sub-endocardial ischemia. Diagnostic coronary angiography revealed significant stenosis in the Cabrol type SVG grafts and we opted for a protected PCI using Impella (Abiomed, Danvers, MA) support. A significant drop in the blood pressure was noted and despite trouble-shooting, the Impella arterial line tracing remained minimally pulsatile.​ A comprehensive understanding of circulatory support physiology was ultimately crucial in making an informed decision for a successful PCI outcome.

Identifiants

pubmed: 32742841
doi: 10.7759/cureus.8829
pmc: PMC7384709
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e8829

Informations de copyright

Copyright © 2020, Siddiqui et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Catheter Cardiovasc Interv. 2010 Feb 1;75(2):187-94
pubmed: 19941329
ASAIO J. 2017 Sep/Oct;63(5):526-535
pubmed: 28323662
J Interv Cardiol. 2019 Apr 9;2019:5243913
pubmed: 31772533
Catheter Cardiovasc Interv. 2017 Jun 1;89(7):E233-E247
pubmed: 28489331
J Am Coll Cardiol. 2011 Feb 8;57(6):688-96
pubmed: 20950980
JACC Cardiovasc Interv. 2015 Feb;8(2):229-244
pubmed: 25700745
Circulation. 2020 Apr 7;141(14):1184-1197
pubmed: 32250695
J Am Coll Cardiol. 2015 Dec 15;66(23):2663-2674
pubmed: 26670067
Catheter Cardiovasc Interv. 2007 Oct 1;70(4):532-7
pubmed: 17896398
JACC Cardiovasc Interv. 2016 May 9;9(9):871-83
pubmed: 27151604

Auteurs

Sabah Siddiqui (S)

Cardiology, Maimonides Medical Center, Brooklyn, USA.
Cardiology, James J. Peters Va Medical Center, Bronx, USA.

Sergey Ayzenberg (S)

Cardiology, Maimonides Medical Center, Brooklyn, USA.

Nitin Sabharwal (N)

Cardiology, Tulane University School of Medicine, New Orleans, USA.

Robert Frankel (R)

Cardiology, Maimonides Medical Center, Brooklyn, USA.

Jacob Shani (J)

Cardiology, Maimonides Medical Center, Brooklyn, USA.

Classifications MeSH